Antibiotic resistance of subgingival species during and after antibiotic therapy

被引:100
作者
Feres, M [1 ]
Haffajee, AD
Allard, K
Som, S
Goodson, JM
Socransky, SS
机构
[1] Guarulhos Univ, Dept Periodontol, Sao Paulo, Brazil
[2] Forsyth Inst, Dept Periodontol, Boston, MA USA
关键词
amoxicillin; antibiotics; bacteria; metronidazole; microbiology; periodontal diseases; periodontitis; resistance; subgingival plaque;
D O I
10.1034/j.1600-051X.2002.290809.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Aim: The purpose of the present investigation was to determine the percentage and identity of antibiotic-resistant species in subgingival plaque and saliva samples from chronic periodontitis patients treated by scaling and root planing followed by orally administered amoxicillin or metronidazole. Method: In all, 20 chronic periodontitis patients were selected for study. After clinical and microbiological monitoring, subjects were randomly assigned to receive either orally administered amoxicillin at the dosage of 500 mg, 3 times daily for 14 days or orally administered metronidazole at the dosage of 250 mg, 3 times daily for 14 days. For the antibiotic resistance determinations, subgingival plaque samples were taken from six posterior teeth at baseline, and 90 days; and from two randomly selected teeth at 3, 7 and 14 days during and after antibiotic administration. Samples were plated on enriched blood agar plates with or without either 2 mug/mL metronidazole or 2 mug/mL amoxicillin. Colonies were counted at 7 days. Significant differences in percentage of resistant organisms over time were determined by the Quade test. Microbial growth was washed from antibiotic-containing media and the identity of species determined using checkerboard DNA-DNA hybridization. Data were compared with those obtained in a previous study from subjects receiving SRP only or SRP followed by 14 days of orally administered doxycycline. The level of doxycycline used to determine antibiotic resistance in that study was 4 mug/mL. Results: The mean percentage of resistant isolates increased during antibiotic administration and returned to baseline levels by 90 days post therapy. The mean percentages (+/-SEM) of isolates resistant to 2 mug/mL metronidazole were 53+/-9, 65 +/- 9, 79 +/- 4 and 69 +/- 7 at baseline, 3, 7 and 14 days during antibiotic administration, and 57 +/- 4, 64 +/- 5, 62 +/- 7 and 47 +/- 6 at 3, 7, 14 and 90 days after antibiotic administration. At the same time points, the percentage of resistant isolates to amoxicillin was 0.5 +/- 0.2, 22 +/- 12, 14 +/- 5 and 37 +/- 11 during, and 31 +/- 11, 8 +/- 3, 3 +/- 2 and 3 +/- 0.6 after, administration. Antibiotic-resistant isolates of resistant species detected during or after therapy were also detected prior to therapy. The most prevalent resistant species in the metronidazole-treated group were: A. naeslundii 1, S. constellatus, A. naeslundii 2, S. mitis, S. oralis, A. odontolyticus, S. sanguis, and in the amoxicillin-treated group: S. constellatus, P. nigrescens, E. saburreum, A. naeslundii 1, S. oralis, P. melaninogenica and P. intermedia. Conclusions: Systemic antibiotic administration transiently increased the percentage of resistant subgingival species, but a major component of subgingival plaque remained sensitive to the agents during their administration. Antibiotic-resistant isolates of resistant species could be detected in samples both prior to and after therapy. However, % antibiotic-resistant isolates returned to baseline levels 90 days after antibiotic administration.
引用
收藏
页码:724 / 735
页数:12
相关论文
共 50 条
[31]   THE BACTERIOLOGY OF ACUTE NECROTIZING ULCERATIVE GINGIVITIS [J].
LOESCHE, WJ ;
SYED, SA ;
LAUGHON, BE ;
STOLL, J .
JOURNAL OF PERIODONTOLOGY, 1982, 53 (04) :223-230
[32]   METRONIDAZOLE THERAPY FOR PERIODONTITIS [J].
LOESCHE, WJ ;
SCHMIDT, E ;
SMITH, BA ;
CAFFESSEE, R ;
STOLL, J .
JOURNAL OF PERIODONTAL RESEARCH, 1987, 22 (03) :224-226
[33]   COMPARISON OF DIFFERENT METRONIDAZOLE THERAPEUTIC REGIMENS FOR BACTERIAL VAGINOSIS - A METAANALYSIS [J].
LUGOMIRO, VI ;
GREEN, M ;
MAZUR, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (01) :92-95
[34]   TREATMENT OF SUBJECTS WITH REFRACTORY PERIODONTAL-DISEASE [J].
MAGNUSSON, I ;
LOW, SB ;
MCARTHUR, WP ;
MARKS, RG ;
WALKER, CB ;
MARUNIAK, J ;
TAYLOR, M ;
PADGETT, P ;
JUNG, J ;
CLARK, WB .
JOURNAL OF CLINICAL PERIODONTOLOGY, 1994, 21 (09) :628-637
[35]   A clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients [J].
Noyan, U ;
Yilmaz, S ;
Karu, B ;
Kadir, T ;
Acar, O ;
Buget, E .
JOURNAL OF CLINICAL PERIODONTOLOGY, 1997, 24 (03) :158-165
[36]   MICROBIOLOGICAL AND CLINICAL EFFECTS OF METRONIDAZOLE AND AMOXICILLIN IN ACTINOBACILLUS ACTINOMYCETEMCOMITANS-ASSOCIATED PERIODONTITIS - A 2-YEAR EVALUATION [J].
PAVICIC, MJAMP ;
VANWINKELHOFF, AJ ;
DOUQUE, NH ;
STEURES, RWR ;
DEGRAAFF, J .
JOURNAL OF CLINICAL PERIODONTOLOGY, 1994, 21 (02) :107-112
[37]   Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease [J].
Poulet, PP ;
Duffaut, D ;
Lodter, JP .
JOURNAL OF CLINICAL PERIODONTOLOGY, 1999, 26 (04) :261-263
[38]  
SCHER KS, 1988, SURG GYNECOL OBSTET, V167, P175
[39]  
SOCRANSKY SS, 1994, BIOTECHNIQUES, V17, P788
[40]  
SODER PO, 1990, J PERIODONTOL, V61, P281